150 related articles for article (PubMed ID: 12723560)
1. EANM procedure guidelines for 32P therapy.
EANM
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP17-9. PubMed ID: 12723560
[No Abstract] [Full Text] [Related]
2. EANM procedure guideline for 32P phosphate treatment of myeloproliferative diseases.
Tennvall J; Brans B
Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1324-7. PubMed ID: 17396258
[TBL] [Abstract][Full Text] [Related]
3. Treatment of the myeloproliferative disorders with 32P.
Berlin NI
Eur J Haematol; 2000 Jul; 65(1):1-7. PubMed ID: 10914933
[TBL] [Abstract][Full Text] [Related]
4. EANM procedure guidelines for therapy with iodine-131.
EANM
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP27-31. PubMed ID: 12723563
[No Abstract] [Full Text] [Related]
5. EANM procedure guidelines for radiosynovectomy.
Clunie G; Fischer M;
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP12-6. PubMed ID: 12723558
[No Abstract] [Full Text] [Related]
6. EANM procedure guidelines for treatment of refractory metastatic bone pain.
Silberstein EB; Taylor AT;
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP7-11. PubMed ID: 12723557
[No Abstract] [Full Text] [Related]
7. Essential thrombocythemia: response during first year of therapy with melphalan and radioactive phosphorus: a polycythemia Vera Study Group report.
Murphy S; Rosenthal DS; Weinfeld A; Briere J; Faguet GB; Knospe WH; Landaw SA; Laszlo J; Pisciotta AV; Tartaglia AP
Cancer Treat Rep; 1982 Jul; 66(7):1495-500. PubMed ID: 7046930
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for 131I-meta-iodobenzylguanidine therapy.
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP23-6. PubMed ID: 12723562
[No Abstract] [Full Text] [Related]
9. Guidelines for 131I-ethiodised oil (Lipiodol) therapy.
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP20-2. PubMed ID: 12723561
[No Abstract] [Full Text] [Related]
10. Radiophosphorus (32P) treatment of bone marrow disorders in dogs: 11 cases (1970-1987).
Smith M; Turrel JM
J Am Vet Med Assoc; 1989 Jan; 194(1):98-102. PubMed ID: 2914806
[TBL] [Abstract][Full Text] [Related]
11. Outcome of 259 patients with primary proliferative polycythaemia (PPP) and idiopathic thrombocythaemia (IT) treated in a regional nuclear medicine department with phosphorus-32--a 15 year review.
Balan KK; Critchley M
Br J Radiol; 1997 Nov; 70(839):1169-73. PubMed ID: 9536909
[TBL] [Abstract][Full Text] [Related]
12. Phosphorus-32: the forgotten radiopharmaceutical?
Vinjamuri S; Ray S
Nucl Med Commun; 2008 Feb; 29(2):95-7. PubMed ID: 18094629
[No Abstract] [Full Text] [Related]
13. The effect of different doses of 32P in the treatment of primary thrombocytosis.
Randi ML; Fabris F; Varotto L; Peverelli P; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):950-6. PubMed ID: 2419226
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia.
Dingli D; Tefferi A
Curr Hematol Malig Rep; 2006 Jun; 1(2):69-74. PubMed ID: 20425334
[TBL] [Abstract][Full Text] [Related]
15. [Radioactive phosphorus (32P); an old, but not bad treatment in polycythemia vera].
Michiels JJ; van Genderen PJ
Ned Tijdschr Geneeskd; 1997 Jan; 141(3):168-9. PubMed ID: 9053768
[No Abstract] [Full Text] [Related]
16. Observations on polycythemia vera turning into acute or chronic granulocytic leukemia during treatment with radioactive phosphorus 32P.
Krańik W
Pol Med Sci Hist Bull (1973); 1975; 15(4):447-52. PubMed ID: 1063385
[TBL] [Abstract][Full Text] [Related]
17. Essential differences in clinical and bone marrow features in BCR/ABL-positive thrombocythemia compared to thrombocythemia in the BCR/ABL-negative myeloproliferative neoplasms essential thrombocythemia and polycythemia vera.
Michiels JJ; Pich A; De Raeve H; Gadisseur A
Acta Haematol; 2015; 133(1):52-5. PubMed ID: 25116159
[No Abstract] [Full Text] [Related]
18. New horizons for therapeutic nuclear medicine in 1981.
Beierwaltes WH
J Nucl Med; 1981 Jun; 22(6):549-54. PubMed ID: 7229726
[TBL] [Abstract][Full Text] [Related]
19. Hematology problem. Myeloproliferative disorders.
Saumur JH; Coleman ML; Larson LM
Am J Med Technol; 1979 Jul; 45(7):634-7. PubMed ID: 573066
[No Abstract] [Full Text] [Related]
20. Radionuclide therapy of hematologic disorders.
Silberstein EB
Semin Nucl Med; 1979 Apr; 9(2):100-7. PubMed ID: 482947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
